Efficacy, Safety, and Tolerability of Eluxadoline in the Treatment of Participants With Diarrhea-Predominant Irritable Bowel Syndrome (IBS-d)
Clinical trial NCT01553591 · COMPLETED
Trial details
- NCT number
- NCT01553591
- Sponsor
- Furiex Pharmaceuticals, Inc
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-05-29
- Primary completion
- 2014-07-29
- Enrollment
- 1282
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.